What can we learn from design faults in the Women's Health Initiative randomized clinical trial?

PubWeight™: 0.76‹?›

🔗 View Article (PMID 19583558)

Published in Bull NYU Hosp Jt Dis on January 01, 2009

Authors

Orkun Tan1, S Mitchell Harman, Frederick Naftolin

Author Affiliations

1: Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA.

Articles by these authors

Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA (2002) 3.36

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48

Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab (2002) 1.70

Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab (2007) 1.70

Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) (2005) 1.60

Is there an antiaging medicine? J Gerontol A Biol Sci Med Sci (2002) 1.46

Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol (2008) 1.44

Biomarkers of aging: from primitive organisms to humans. J Gerontol A Biol Sci Med Sci (2004) 1.44

Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol (2006) 1.35

Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab (2002) 1.26

Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (2006) 1.18

Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11

Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Ann N Y Acad Sci (2005) 1.04

Tart cherry juice decreases oxidative stress in healthy older men and women. J Nutr (2009) 1.04

Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett (2002) 1.03

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med (2003) 1.03

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02

Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. Cancer Lett (2005) 1.01

Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause (2003) 1.01

Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia. FASEB J (2005) 1.01

Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis (2011) 0.99

Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann N Y Acad Sci (2005) 0.99

Is the WHI relevant to HRT started in the perimenopause? Endocrine (2004) 0.97

Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab (2005) 0.95

The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril (2004) 0.93

Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93

Advantages of the dental practice-based research network initiative and its role in dental education. J Dent Educ (2011) 0.91

Oxidative stress in older adults: effects of physical fitness. Age (Dordr) (2011) 0.91

Person-centric clinical trials: an opportunity for the good clinical practice (GCP)-practice-based research network. J Clin Pharmacol (2013) 0.90

Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. Am J Physiol Endocrinol Metab (2006) 0.88

Ischemia/reperfusion unveils impaired capacity of older adults to restrain oxidative insult. Free Radic Biol Med (2009) 0.87

The pros and cons of plant estrogens for menopause. J Steroid Biochem Mol Biol (2012) 0.87

Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. Neuropsychopharmacology (2006) 0.86

Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol (2012) 0.86

Vinegar lacks antiglycemic action on enteral carbohydrate absorption in human subjects. Nutr Res (2009) 0.85

Modern pathology: protein mis-folding and mis-processing in complex disease. Curr Protein Pept Sci (2007) 0.85

The application of umbilical cord blood cells in the treatment of diabetes mellitus. Rev Diabet Stud (2006) 0.85

Estrogens regulate posttranslational modification of neural cell adhesion molecule during the estrogen-induced gonadotropin surge. Endocrinology (2009) 0.84

Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men. Am J Physiol Endocrinol Metab (2007) 0.83

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83

The Timing Hypothesis remains a valid explanation of differential cardioprotective effects of menopausal hormone treatment. Menopause (2011) 0.83

Estradiol regulates expression of polysialated neural cell adhesion molecule by human vascular endothelial cells. Reprod Sci (2010) 0.83

High-dose statin use does not impair aerobic capacity or skeletal muscle function in older adults. Age (Dordr) (2008) 0.83

Neuroendocrine control of ovulation. Gynecol Endocrinol (2012) 0.82

Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells. Mol Hum Reprod (2002) 0.82

Controlled fine needle biopsy of the uterine cervix during pregnancy. Reprod Sci (2011) 0.82

Is progestogen supplementation of ERT really necessary? Menopause (2002) 0.81

Masculine vitality: pros and cons of testosterone in treating the andropause. J Gerontol A Biol Sci Med Sci (2004) 0.81

Angiotensin II induces apoptosis in human mural granulosa-lutein cells, but not in cumulus cells. Fertil Steril (2008) 0.80

Brain health and cognitive and mood disorders in ageing women. Best Pract Res Clin Obstet Gynaecol (2013) 0.80

The resistance to depressive relapse in menopausal women undergoing tryptophan depletion: preliminary findings. J Psychopharmacol (2006) 0.80

Minimally invasive method for murine brain fixation. Biotechniques (2005) 0.80

Effects of growth hormone and/or sex steroid administration on whole-body protein turnover in healthy aged women and men. Metabolism (2005) 0.80

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. PLoS One (2013) 0.80

Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study. Obesity (Silver Spring) (2013) 0.79

Dehydroepiandrosterone (DHEA) inhibition of monocyte binding by vascular endothelium is associated with sialylation of neural cell adhesion molecule. Reprod Sci (2012) 0.79

Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy. Menopause (2006) 0.79

The evolutionary origin and significance of menopause. Menopause (2011) 0.78

Can menopausal hormone therapy prevent coronary heart disease? Trends Endocrinol Metab (2008) 0.78

Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography. Am J Cardiol (2003) 0.78

Estradiol-induced synaptic remodeling of tyrosine hydroxylase immunopositive neurons in the rat arcuate nucleus. Endocrinology (2008) 0.78

Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol A Biol Sci Med Sci (2002) 0.78

Development of low-dose reproductive hormone therapies in China. Gynecol Endocrinol (2006) 0.78

Menopause: developing a rational treatment plan. Gynecol Endocrinol (2007) 0.77

Effects of testosterone administration on nocturnal cortisol secretion in healthy older men. J Gerontol A Biol Sci Med Sci (2010) 0.77

Expression and activation of the membrane-cytoskeleton protein ezrin during the normal endometrial cycle. Fertil Steril (2012) 0.77

Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men. J Clin Endocrinol Metab (2006) 0.77

Depot-medroxyprogesterone acetate: an update. Arch Gynecol Obstet (2008) 0.77

Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. J Clin Endocrinol Metab (2009) 0.77

Phytoestrogens: are they really estrogen mimics? Fertil Steril (2002) 0.76

Comparison of the effects of atorvastatin versus simvastatin on subclinical atherosclerosis in primary preventionas determined by electronbeam tomography. Am J Cardiol (2003) 0.76

Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis. Am J Physiol Endocrinol Metab (2006) 0.76

Evaluation by electron beam tomography of changes in calcified coronary plaque in treated and untreated asymptomatic patients and relation to serum lipid levels. Am J Cardiol (2003) 0.76

Protein flexibility and conformational states of Leishmania antigen eIF-4A: identification of a novel plausible protein adjuvant using comparative genomics and molecular modeling. J Biomol Struct Dyn (2012) 0.76

Antiaging technology and pseudoscience. Science (2002) 0.75

Stopping HABITS. Lancet (2004) 0.75

Sex steroids and the brain. Gynecol Endocrinol (2008) 0.75

Preventing Alzheimer disease and cognitive decline. Ann Intern Med (2011) 0.75

Abnormal fingernail beds following carbon monoxide poisoning: a case report and review of the literature. J Med Case Rep (2014) 0.75

Expression of angiotensin II type 1 (AT1) and angiotensin II type 2 (AT2) receptors in human granulosa-lutein (GL) cells: correlation with infertility diagnoses. Fertil Steril (2009) 0.75

Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial. Ann Intern Med (2010) 0.75

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause (2016) 0.75

Practice based research networks impacting periodontal care: PEARL Initiative. J Periodontol (2012) 0.75

Csapo redux, but more veils remain. J Soc Gynecol Investig (2002) 0.75

Progesterone abolishes estrogen and/or atorvastatin endothelial dependent vasodilatory effects. Atherosclerosis (2005) 0.75

Relation of response of subclinical atherosclerosis detected by electron beam tomography to baseline low-density lipoprotein cholesterol levels. Am J Cardiol (2004) 0.75

ISGE statement on oral emergency contraception. Gynecol Endocrinol (2014) 0.75

Unveiling the unfolding pathway of F5F8D disorder-associated D81H/V100D mutant of MCFD2 via multiple molecular dynamics simulations. J Biomol Struct Dyn (2012) 0.75

Toward optimal health: managing women's medical challenges in midlife. J Womens Health (Larchmt) (2008) 0.75

The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women. Menopause (2011) 0.75